Does it make sense evaluating cardiac resynchronization therapy in the elderly regardless of the type of the device?
Mehmet Tezcan
Omer Uz
Gokhan Degirmencioglu
Mustafa Aparci
摘要：We read the research article entitled Is cardiac resynchronisation therapy feasible,safe and beneficial in the very elderly? with great interest.[1] The authors emphasized that despite the average age of heart failure was 77 years in the general population of UK,[2] patients receiving cardiac resynchronisation therapy [with pacemaker alone (CRT-P) or with additional defibrillator capabilities (CRT-D)] were on younger ages at 72 and 67 years respectively.[3] In the lights of this data,we agree with the authors that CRT seems to be underutilized in the elderly patients with heart failure.Given the well-proven benefits of CRT,it is wise to conduct such a study in order to evaluate the safety and benefits of CRT in the elderly,among the concems of co-morbidities and potential complications.
机标关键词：
论文发表日期：2016-09-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
英文信息